US Stock MarketDetailed Quotes
SER Serina Therapeutics
- 8.930
- +1.540+20.84%
Close Jul 12 16:00 ET
- 9.240
- +0.310+3.47%
Post 18:29 ET
75.14MMarket Cap-148833P/E (TTM)
9.749High7.500Low34.19KVolume7.500Open7.390Pre Close297.41KTurnover1.32%Turnover RatioLossP/E (Static)8.41MShares31.16452wk High-17.44P/B23.17MFloat Cap5.92652wk Low--Dividend TTM2.59MShs Float209.262Historical High--Div YieldTTM30.43%Amplitude5.926Historical Low8.699Avg Price1Lot Size
About Serina Therapeutics Company
Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.
Company Profile
SymbolSER
Company NameSerina Therapeutics
Listing DateNov 29, 2018
Founded2024
CEOMr. Steven Ledger
MarketAMEX
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address601 Genome Way,Suite 2001
CityHuntsville
ProvinceAlabama
CountryUnited States of America
Zip Code35806
Phone1-256-327-9630
Company Executives
- Name
- Position
- Salary
- Steven Ledger
- Director and Interim Chief Executive Officer
- --
- Dr. Randall W. Moreadith,M.D.,PhD
- Chief Scientific Officer
- --
- Andrea E. Park
- Interim Chief Financial Officer and Chief Accounting Officer
- --
- Dr. Tacey Viegas, PhD
- Chief Operating Officer and Secretary
- --
- Dr. Simba Gill, PhD
- Chairman of the Board
- --
- Steven M. Mintz
- Independent Director
- --
- J. Milton Harris, PhD
- Independent Director
- --
- Dr. Richard Marshall, M.D.
- Independent Director
- --
- Remy Gross
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
